RETROVIR Safety Questions, RETROVIR Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about RETROVIR. Our extensive database of RETROVIR adverse events and RETROVIR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about RETROVIR
RETROVIR Safety Reports
Total RETROVIR reports: 100.RETROVIR FDA safety alerts: 2002 2003 2005 2006 2007 .
Reported deaths: 4 Reported hospitalizations: 70.
Take RETROVIR Side Effects Survey or Share Your RETROVIR Story. RETROVIR Usage.
Showing 1-75 of 100 Next >
Consumer or non-health professional from FRANCE reported RETROVIR problem on June 24, 2002. Female patient, weighting 5.07 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: accidental overdose, foetal distress syndrome, hepatomegaly. RETROVIR dosage: unknown. During the same period patient was treated with COMBIVIR, VIRACEPT, BACTRIM. Patient was hospitalized. Patient recovered.RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on July 01, 2002. Female patient, weighting 4.85 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: amblyopia, anaemia macrocytic, astigmatism, communication disorder, developmental delay, hypermetropia, macrocytosis, thrombocythaemia. RETROVIR dosage: unknown. During the same period patient was treated with ZOVIRAX, SPASFON, GYNOPEVARYL, CLAMOXYL, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on July 01, 2002. Male patient, weighting 3.09 lb, was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anaemia, hypertonia, neutropenia, overdose, respiratory distress, restlessness, thrombocythaemia. RETROVIR dosage: unknown. During the same period patient was treated with SALBUTAMOL, METHADONE. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Feb 28, 2001. Male patient, weighting 4.19 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anaemia, anaemia neonatal, premature baby, regurgitation of food, sickle cell anaemia. RETROVIR dosage: unknown. During the same period patient was treated with ZIDOVUDINE, VIRAMUNE, VIDEX, SAQUINAVIR, RITONAVIR, CLAMOXYL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Jan 30, 2002. Male patient, weighting 7.72 lb, was diagnosed with antiviral prophylaxis, hiv infection, hypertension and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: foot deformity, neutropenia, restlessness. RETROVIR dosage: unknown. During the same period patient was treated with SECTRAL, MYCOSTER, VITAMINS. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Feb 01, 2002. Male patient was diagnosed with hiv infection, antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: communication disorder, foetal distress syndrome, neonatal disorder, speech disorder developmental, thrombocythaemia, thrombocytopenia neonatal. RETROVIR dosage: 100MG FIVE TIMES PER DAY. During the same period patient was treated with EPIVIR, ZALCITABINE, COTRIM D, IRON SALTS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Oct 01, 2002. Male patient, weighting 6.39 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anorexia, caesarean section, developmental delay, dysgraphia, hydrocele, hypertonia, neutropenia, speech disorder developmental. RETROVIR dosage: unknown. During the same period patient was treated with PENTAMIDINE ISETHIONATE, VENTOLIN. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Oct 01, 2002. Male patient, weighting 7.28 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, craniosynostosis, neutropenia, neutropenia neonatal, platelet count increased, talipes, visual acuity reduced. RETROVIR dosage: unknown. During the same period patient was treated with COMBIVIR, VIRACEPT, BACTRIM, SPASFON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Nov 27, 2002. Female patient, weighting 6.17 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood creatine phosphokinase increased, heart disease congenital, transaminases increased, ventricular septal defect. RETROVIR dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR, SKENAN, METHADONE. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Dec 05, 2002. Female patient, weighting 7.05 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, hyperkalaemia, overdose. RETROVIR dosage: unknown. During the same period patient was treated with EPIVIR. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Dec 22, 2000. Female patient, weighting 7.50 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anaemia, blood lactic acid increased, hypotonia, microcytosis, neutropenia, oral fungal infection. RETROVIR dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE, GYNOMYK. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Nov 29, 2006. Female patient, weighting 5.95 lb, was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, anaemia, hyperkalaemia, hypocalcaemia, hyponatraemia, hypotonia. RETROVIR dosage: 8MGKD PER DAY. During the same period patient was treated with EPIVIR, AUGMENTIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Feb 21, 2001. Female patient, weighting 7.05 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abnormal faeces, anaemia, anaemia neonatal, blood cholesterol increased, blood creatine phosphokinase increased, blood ketone body, blood ketone body present, blood lactic acid increased. RETROVIR dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE, RITONAVIR, SAQUINAVIR, EFAVIRENZ, DIDANOSINE. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Nov 29, 2006. Female patient was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anaemia, anaemia neonatal, granulocytopenia. RETROVIR dosage: .65MG FOUR TIMES PER DAY. During the same period patient was treated with EPIVIR. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Nov 21, 2006. Female patient was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: caesarean section, depressed level of consciousness, electroencephalogram abnormal, feeding disorder neonatal, hypertonia neonatal, hyperventilation. RETROVIR dosage: .6ML FOUR TIMES PER DAY. During the same period patient was treated with MORPHIN CHLORHYDRATE, EPIVIR, ROHYPNOL, SUBUTEX, ZERIT, VIRACEPT. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Health Professional from BOTSWANA on Dec 08, 2006. Female patient, 33 years of age, was diagnosed with hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: stillbirth. RETROVIR dosage: 600MG PER DAY. During the same period patient was treated with VIRACEPT, VIRAMUNE, VIDEX, SUSTIVA. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on Dec 15, 2006. Male patient was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anaemia, anaemia neonatal, blood lactic acid increased, caesarean section, diarrhoea, gamma-glutamyltransferase increased, gastroenteritis. RETROVIR dosage: 8MGKD PER DAY. During the same period patient was treated with COMBIVIR, VIRACEPT, CLAMOXYL, HEP B VACCINE. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Male patient was diagnosed with hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. RETROVIR dosage: 17.5MG FOUR TIMES PER DAY. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on July 16, 2007. Male patient, 52 years of age, was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic pain, hepatic steatosis, hepatomegaly, hypertriglyceridaemia, lactic acidosis, myalgia. RETROVIR dosage: unknown. During the same period patient was treated with VIREAD, NORVIR, DARUNAVIR. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Health Professional from GERMANY on July 20, 2007. Female patient, weighting 5.73 lb, was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: accidental overdose. RETROVIR dosage: 52MG PER DAY. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported RETROVIR problem on July 25, 2007. Female patient, weighting 8.60 lb, was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anaemia. RETROVIR dosage: unknown. During the same period patient was treated with ZIDOVUDINE. Patient was hospitalized. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2007. Male patient, weighting 7.72 lb, was diagnosed with hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic enzyme increased. RETROVIR dosage: 17.5MG FOUR TIMES PER DAY. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RETROVIR problem on Aug 16, 2007. Female patient, weighting 5.73 lb, was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. RETROVIR dosage: 600MG PER DAY. During the same period patient was treated with KALETRA, DIDANOSINE. Patient recovered.
RETROVIR problem was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2007. Male patient, weighting 6.61 lb, was diagnosed with antiviral prophylaxis, hiv infection and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal disorder, hypoglycaemia, hyponatraemia, protein total decreased, tremor. RETROVIR dosage: .46ML FOUR TIMES PER DAY. During the same period patient was treated with COMBIVIR, VIRACEPT, KALETRA. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RETROVIR problem on Sept 20, 2007. Female patient, weighting 6.17 lb, was diagnosed with antiviral prophylaxis and was treated with RETROVIR. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, incorrect dose administered, overdose. RETROVIR dosage: 56MG PER DAY. Patient recovered.
Showing 1-75 of 100 Next >
This
drug has an active FDA Safety Alert